{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T02:46:26Z","timestamp":1780368386056,"version":"3.54.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,1,18]],"date-time":"2011-01-18T00:00:00Z","timestamp":1295308800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1007\/s10147-010-0170-6","type":"journal-article","created":{"date-parts":[[2011,1,17]],"date-time":"2011-01-17T05:03:58Z","timestamp":1295240638000},"page":"244-249","source":"Crossref","is-referenced-by-count":30,"title":["High-dose dexamethasone plus antihistamine prevents colorectal cancer patients treated with modified FOLFOX6 from hypersensitivity reactions induced by oxaliplatin"],"prefix":"10.1007","volume":"16","author":[{"given":"Yasuhiro","family":"Kidera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taroh","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isamu","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soichi","family":"Fumita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimio","family":"Yonesaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetoshi","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chihiro","family":"Makimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunio","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidemi","family":"Kiyota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Tsurutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Yoshinaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimiko","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzuru","family":"Yamazoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenzo","family":"Moriyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanobu","family":"Tsubaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasutaka","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shozo","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,1,18]]},"reference":[{"key":"170_CR1","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1056\/NEJMoa032709","volume":"350","author":"T Andre","year":"2004","unstructured":"Andre T, Boni C, Mounedji-Boudiaf L et al (2004) Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350:2343\u20132351","journal-title":"N Engl J Med"},{"key":"170_CR2","doi-asserted-by":"crossref","first-page":"606","DOI":"10.5414\/CPP45606","volume":"45","author":"D Rosique-Robles","year":"2007","unstructured":"Rosique-Robles D, Vicent Verge JM, Borras-Blasco J et al (2007) Successful desensitization protocol for hypersensitivity reactions caused by oxaliplatin. Int J Clin Pharmacol Ther 45:606\u2013610","journal-title":"Int J Clin Pharmacol Ther"},{"key":"170_CR3","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1345\/aph.1E532","volume":"39","author":"L Mis","year":"2005","unstructured":"Mis L, Fernando NH, Hurwitz HI et al (2005) Successful desensitization to oxaliplatin. Ann Pharmacother 39:966\u2013969","journal-title":"Ann Pharmacother"},{"key":"170_CR4","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1164\/ajrccm.160.2.9807065","volume":"160","author":"AJ Newman Taylor","year":"1999","unstructured":"Newman Taylor AJ, Cullinan P, Lympany PA et al (1999) Interaction of HLA phenotype and exposure intensity in sensitization to complex platinum salts. Am J Respir Crit Care Med 160:435\u2013438","journal-title":"Am J Respir Crit Care Med"},{"key":"170_CR5","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1200\/JCO.2001.19.12.3126","volume":"19","author":"KM Zanotti","year":"2001","unstructured":"Zanotti KM, Rybicki LA, Kennedy AW et al (2001) Carboplatin skin testing: a skin-testing protocol for predicting hypersensitivity to carboplatin chemotherapy. J Clin Oncol 19:3126\u20133129","journal-title":"J Clin Oncol"},{"key":"170_CR6","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1159\/000205263","volume":"76","author":"BH Kim","year":"2009","unstructured":"Kim BH, Bradley T, Tai J et al (2009) Hypersensitivity to oxaliplatin: an investigation of incidence and risk factors, and literature review. Oncology 76:231\u2013238","journal-title":"Oncology"},{"key":"170_CR7","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/sj.bjc.6601155","volume":"89","author":"G Brandi","year":"2003","unstructured":"Brandi G, Pantaleo MA, Galli C et al (2003) Hypersensitivity reactions related to oxaliplatin (OHP). Br J Cancer 89:477\u2013481","journal-title":"Br J Cancer"},{"key":"170_CR8","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/00001813-200310000-00007","volume":"14","author":"G Lenz","year":"2003","unstructured":"Lenz G, Hacker UT, Kern W et al (2003) Adverse reactions to oxaliplatin: a retrospective study of 25 patients treated in one institution. Anticancer Drugs 14:731\u2013733","journal-title":"Anticancer Drugs"},{"key":"170_CR9","unstructured":"Gowda A, Goel R, Berdzik J, et al (2004) Hypersensitivity reactions to oxaliplatin: incidence and management. Oncology (Williston Park) 18:1671\u20131675 (discussion 1676, 1680, 1683\u20131684)"},{"key":"170_CR10","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/annonc\/mdj042","volume":"17","author":"SW Siu","year":"2006","unstructured":"Siu SW, Chan RT, Au GK (2006) Hypersensitivity reactions to oxaliplatin: experience in a single institute. Ann Oncol 17:259\u2013261","journal-title":"Ann Oncol"},{"key":"170_CR11","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s004320050297","volume":"125","author":"M Markman","year":"1999","unstructured":"Markman M, Kennedy A, Webster K et al (1999) An effective and more convenient drug regimen for prophylaxis against paclitaxel-associated hypersensitivity reactions. J Cancer Res Clin Oncol 125:427\u2013429","journal-title":"J Cancer Res Clin Oncol"},{"key":"170_CR12","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/CAD.0b013e32802ffbcb","volume":"18","author":"SH Wrzesinski","year":"2007","unstructured":"Wrzesinski SH, McGurk ML, Donovan CT et al (2007) Successful desensitization to oxaliplatin with incorporation of calcium gluconate and magnesium sulfate. Anticancer Drugs 18:721\u2013724","journal-title":"Anticancer Drugs"},{"key":"170_CR13","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000107467","volume":"145","author":"M Pagani","year":"2008","unstructured":"Pagani M, Bonadonna P, Senna GE et al (2008) Standardization of skin tests for diagnosis and prevention of hypersensitivity reactions to oxaliplatin. Int Arch Allergy Immunol 145:54\u201357","journal-title":"Int Arch Allergy Immunol"},{"key":"170_CR14","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2006.09.6305","volume":"25","author":"BJ Giantonio","year":"2007","unstructured":"Giantonio BJ, Catalano PJ, Meropol NJ et al (2007) Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200. J Clin Oncol 25:1539\u20131544","journal-title":"J Clin Oncol"},{"key":"170_CR15","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1200\/JCO.2007.14.9930","volume":"26","author":"LB Saltz","year":"2008","unstructured":"Saltz LB, Clarke S, Diaz-Rubio E et al (2008) Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study. J Clin Oncol 26:2013\u20132019","journal-title":"J Clin Oncol"},{"key":"170_CR16","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1200\/JCO.2006.06.1317","volume":"24","author":"RM Goldberg","year":"2006","unstructured":"Goldberg RM, Sargent DJ, Morton RF et al (2006) Randomized controlled trial of reduced-dose bolus fluorouracil plus leucovorin and irinotecan or infused fluorouracil plus leucovorin and oxaliplatin in patients with previously untreated metastatic colorectal cancer: a North American Intergroup Trial. J Clin Oncol 24:3347\u20133353","journal-title":"J Clin Oncol"},{"key":"170_CR17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1200\/JCO.2004.05.113","volume":"22","author":"C Tournigand","year":"2004","unstructured":"Tournigand C, Andre T, Achille E et al (2004) FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 22:229\u2013237","journal-title":"J Clin Oncol"},{"key":"170_CR18","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/1078155207079877","volume":"13","author":"N Kitada","year":"2007","unstructured":"Kitada N, Dan T, Takara K et al (2007) Oxaliplatin-induced hypersensitivity reaction displaying marked elevation of immunoglobulin E. J Oncol Pharm Pract 13:233\u2013235","journal-title":"J Oncol Pharm Pract"},{"key":"170_CR19","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1016\/j.ejca.2005.06.021","volume":"41","author":"F Maindrault-Goebel","year":"2005","unstructured":"Maindrault-Goebel F, Andre T, Tournigand C et al (2005) Allergic-type reactions to oxaliplatin: retrospective analysis of 42 patients. Eur J Cancer 41:2262\u20132267","journal-title":"Eur J Cancer"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-010-0170-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-010-0170-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-010-0170-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T22:39:14Z","timestamp":1559947154000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-010-0170-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,18]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["170"],"URL":"https:\/\/doi.org\/10.1007\/s10147-010-0170-6","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,18]]}}}